| # | Drug | Count |
|---|---|---|
| 0 | CERTOLIZUMAB PEGOL | 4 |
| 1 | CANDESARTAN CILEXETIL | 2 |
| 2 | METHOTREXATE | 2 |
| 3 | METHOTREXATE SODIUM | 2 |
| 4 | NIRSEVIMAB | 2 |
| 5 | RELUGOLIX | 2 |
| 6 | ROSUVASTATIN | 2 |
| 7 | TADALAFIL | 2 |
| 8 | ALBUTEROL SULFATE | 1 |
| 9 | ATORVASTATIN CALCIUM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NIRSEVIMAB | 2 | 0.0011 |
| 1 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 2 | PILOCARPINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 4 | CANDESARTAN CILEXETIL | 2 | 0.0001 |
| 5 | BIMEKIZUMAB | 1 | 0.0000 |
| 6 | ROSUVASTATIN | 2 | 0.0000 |
| 7 | TADALAFIL | 2 | 0.0000 |
| 8 | FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE | 1 | 0.0000 |
| 9 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 2 | 0.0011 |
| 1 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 2 | 0.0001 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 4 | 0.0000 |
| 5 | Vitamin D [EPC] | 1 | 0.0000 |
| 6 | Vitamin B12 [EPC] | 1 | 0.0000 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Vitamin C [EPC] | 1 | 0.0000 |
| 9 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |